HK1208529A1 - Method for predicting implantation success in assisted fertilisation - Google Patents

Method for predicting implantation success in assisted fertilisation

Info

Publication number
HK1208529A1
HK1208529A1 HK15109190.2A HK15109190A HK1208529A1 HK 1208529 A1 HK1208529 A1 HK 1208529A1 HK 15109190 A HK15109190 A HK 15109190A HK 1208529 A1 HK1208529 A1 HK 1208529A1
Authority
HK
Hong Kong
Prior art keywords
csf
implantation success
assisted fertilisation
follicular fluid
predicting
Prior art date
Application number
HK15109190.2A
Other languages
English (en)
Chinese (zh)
Inventor
Nathalie Lde
Marie-Pierre Piccinni
Raoul Lombroso
Original Assignee
Femalon S P R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Femalon S P R L filed Critical Femalon S P R L
Publication of HK1208529A1 publication Critical patent/HK1208529A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15109190.2A 2006-07-21 2015-09-18 Method for predicting implantation success in assisted fertilisation HK1208529A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83209406P 2006-07-21 2006-07-21

Publications (1)

Publication Number Publication Date
HK1208529A1 true HK1208529A1 (en) 2016-03-04

Family

ID=38529962

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09104568.5A HK1128760A1 (en) 2006-07-21 2009-05-19 Assay and kit for predicting implantation success in assisted fertilisation
HK15109190.2A HK1208529A1 (en) 2006-07-21 2015-09-18 Method for predicting implantation success in assisted fertilisation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09104568.5A HK1128760A1 (en) 2006-07-21 2009-05-19 Assay and kit for predicting implantation success in assisted fertilisation

Country Status (21)

Country Link
US (1) US8211650B2 (xx)
EP (5) EP2049906B1 (xx)
JP (1) JP5052609B2 (xx)
KR (2) KR101482568B1 (xx)
CN (2) CN106199004B (xx)
AT (1) ATE468538T1 (xx)
AU (1) AU2007275112B2 (xx)
BR (1) BRPI0714494B1 (xx)
CA (1) CA2658665C (xx)
DE (1) DE602007006672D1 (xx)
DK (2) DK2049906T3 (xx)
EA (1) EA016348B1 (xx)
ES (4) ES2754707T3 (xx)
HK (2) HK1128760A1 (xx)
HR (2) HRP20100382T8 (xx)
MX (1) MX2009000569A (xx)
MY (1) MY150687A (xx)
NZ (1) NZ574135A (xx)
PL (2) PL2214021T3 (xx)
PT (2) PT2049906E (xx)
WO (1) WO2008009705A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
ES2405506T3 (es) 2003-10-24 2013-05-31 Nora Therapeutics, Inc. Un método para obtener datos útiles en la identificación de un paciente con riesgo de tener dificultad de llevar a término un embarazo
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US9176145B2 (en) 2006-07-21 2015-11-03 Femalon S.P.R.L. Kit for predicting implantation success in assisted fertilization
GB0806281D0 (en) * 2008-04-07 2008-05-14 Univ Leeds Markers of Oocyte viability
WO2009134633A1 (en) * 2008-05-01 2009-11-05 Zymogenetics, Inc. Levels of blys/april heterotrimers in serum and use in diagnostic methods
WO2010126528A1 (en) * 2009-05-01 2010-11-04 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US20120196316A1 (en) * 2009-06-25 2012-08-02 Phase Holographic Imaging Phi Ab Analysis of ova or embryos with digital holographic imaging
WO2011000805A1 (en) 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
US9753042B2 (en) 2013-04-23 2017-09-05 Rosalind Franklin University Of Medicine And Science Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
EP3126836A4 (en) * 2014-04-02 2017-11-08 Prince Henry's Insitute of Medical Research Trading as The Hudson Institute of Medical Research A prognostic assay for succes of assisted reproductive technology
CN104450904A (zh) * 2014-12-02 2015-03-25 柳州市妇幼保健院 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法
WO2017054038A1 (en) 2015-09-30 2017-04-06 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research A method of treatment and prognosis
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2746644C1 (ru) * 2021-01-21 2021-04-19 Мекан Рахимбердыевич Оразов Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
NZ228482A (en) 1988-03-24 1991-03-26 Terrapin Tech Inc Chromatography substrate containing a peptide paralog (active site mimicer) peptide
JP3058673B2 (ja) * 1989-11-10 2000-07-04 株式会社明電舎 サイトカインの測定方法及びその測定用キット
GB9603326D0 (en) 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
DE60236522D1 (de) * 2001-07-11 2010-07-08 Maxygen Inc G-csf konjugate

Also Published As

Publication number Publication date
EP3267198A1 (en) 2018-01-10
CA2658665A1 (en) 2008-01-24
ES2634527T3 (es) 2017-09-28
EP3267198B1 (en) 2019-09-04
EP2214021A1 (en) 2010-08-04
US8211650B2 (en) 2012-07-03
CN106199004A (zh) 2016-12-07
HRP20100382T8 (en) 2010-10-31
ES2754707T3 (es) 2020-04-20
WO2008009705A1 (en) 2008-01-24
AU2007275112A1 (en) 2008-01-24
EP2049906B1 (en) 2010-05-19
PT2214021E (pt) 2015-03-11
EA016348B1 (ru) 2012-04-30
PL2049906T3 (pl) 2010-10-29
US20090312596A1 (en) 2009-12-17
EP2857840A1 (en) 2015-04-08
EP2857840B1 (en) 2017-06-14
DE602007006672D1 (de) 2010-07-01
KR20090056986A (ko) 2009-06-03
MY150687A (en) 2014-02-28
PT2049906E (pt) 2010-08-02
BRPI0714494B1 (pt) 2018-05-08
ES2345571T3 (es) 2010-09-27
MX2009000569A (es) 2009-06-19
EP2857840B8 (en) 2017-08-02
EA200900210A1 (ru) 2009-06-30
PL2214021T3 (pl) 2015-06-30
ATE468538T1 (de) 2010-06-15
JP2009544934A (ja) 2009-12-17
CN106199004B (zh) 2019-04-09
DK2049906T3 (da) 2010-07-05
EP2214021B1 (en) 2015-01-07
CA2658665C (en) 2017-09-26
NZ574135A (en) 2011-11-25
CN101495871A (zh) 2009-07-29
KR20140040289A (ko) 2014-04-02
HRP20100382T1 (hr) 2010-08-31
EP3627156A1 (en) 2020-03-25
ES2531853T3 (es) 2015-03-20
BRPI0714494A2 (pt) 2013-05-14
JP5052609B2 (ja) 2012-10-17
EP2049906A1 (en) 2009-04-22
AU2007275112B2 (en) 2012-07-12
HRP20150251T1 (xx) 2015-06-05
KR101482568B1 (ko) 2015-01-14
DK2214021T3 (en) 2015-02-16
HK1128760A1 (en) 2009-11-06

Similar Documents

Publication Publication Date Title
HK1208529A1 (en) Method for predicting implantation success in assisted fertilisation
EA201101141A1 (ru) Получение закрытой линейной днк
MY172864A (en) Noninvasive detection of fetal genetic abnormality
DE602007004771D1 (de) Verfahren zur quantitativen cDNA-Analyse in Einzelzellen
CL2008001159A1 (es) Metodo para producir una proteina en un cultivo de celulas que comprende cultivar celulas a una temperatura reducida y/o cultivar celulas a un ph reducido para minimizar la produccion de proteinas mal plegadas y/o proteinas agregadas.
WO2013009890A3 (en) Methods for data collection and distribution
EP2657697A3 (en) Methods for determining the risk of chromosomal abnormality in a fetus
FR2939558B1 (fr) Procede de modelisation meteorologique pour le calcul d'un plan de vol d'aeronef
WO2009125219A3 (en) Markers of oocyte viability
FR2916841B1 (fr) Procede d'elaboration d'un plan de vol d'aeronef
WO2008024769A3 (en) Intensified perfusion production method
WO2007126938A3 (en) Marker for chromosomal abnormalities
WO2014155105A3 (en) Assessment of risk of aneuploidy
Tessaro et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test
GB201121561D0 (en) Transgenic animal
WO2009059289A3 (en) Netrin-1 compositions and methods of use thereof
ATE529503T1 (de) Differenzierte zellen mit ursprung in vorläuferfettzellen sowie verfahren zur gewinnung davon
BR112017007213A2 (pt) "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero"
FR2977145B1 (fr) Sonde intra-uterine pour l'insemination artificielle d'un animal, notamment de race porcine.
Sepulveda et al. Comparison of a single medium with sequential media for culture of sibling human embryos to the blastocyst stage
Nõmm et al. Low molecular weight metabolites as possible new non-invasive tool for selecting bovine in vitro produced embryos
WO2013023040A3 (en) Stem cell therapy using inhibitors of lysophosphatidic acid
UA94479C2 (ru) Способ определения стадии эструса у норок клеточного разведения
UA39101U (ru) Способ прогнозирования эффективности осеменения свиноматок замороженной-оттаявшей спермой
Todorova et al. Gene Panel in Human Cumulus Cells as Biomarker for Successful in vitro Procedures

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220715